Assessing Whether AMETEK (AME) Still Looks Undervalued After Its Recent Share Price Momentum

Without a fresh company specific headline driving attention, AMETEK (AME) is drawing interest as investors look at its recent returns and current fundamentals to reassess where the stock now stands.

See our latest analysis for AMETEK.

At a latest share price of $210.64, AMETEK’s recent 90 day share price return of 15.58% and 1 year total shareholder return of 20.38% suggest momentum has been building rather than fading.

If AMETEK’s steady run has you thinking about what else is working in industrials and beyond, broaden your search with fast growing stocks with high insider ownership.

With AMETEK trading around $210.64, sitting roughly 8% below consensus price targets yet carrying an intrinsic value estimate that is about 20% higher, the key question is whether there is still a buying opportunity or if the market is already pricing in future growth.

With AMETEK closing at $210.64 against a narrative fair value of $223.18, the current setup hinges on how future margins and earnings play out.

EMG and Automation segments are inflecting upwards, with destocking now complete and record orders translating to accelerating organic growth and strong core margin expansion. This shift is poised to further enhance operating leverage and group EBITDA growth in coming quarters.

Read the complete narrative.

Curious what is baked into that premium fair value? Revenue stepping up, margins edging higher, and a richer earnings multiple all sit at the center of this narrative. The full story connects those assumptions into one cohesive path for returns.

Result: Fair Value of $223.18 (UNDERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, weakness in semiconductor and research end markets, plus any stumble integrating acquisitions like FARO or Paragon, could quickly challenge the margin and valuation story that investors are watching.

Find out about the key risks to this AMETEK narrative.

That 5.6% narrative undervaluation is only one angle. Our DCF model points the other way, with a fair value of about $175.22 per share versus today’s $210.64, which screens as overvalued. It raises a simple question for you: are near term expectations running ahead of the cash flow math?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out AMETEK for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 882 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match – so you never miss a potential opportunity.